ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · IEX Real-Time Price · USD
4.52
0.00 (0.00%)
At close: Dec 29, 2023, 4:00 PM
4.53
+0.01 (0.24%)
After-hours: Dec 29, 2023, 7:17 PM EST
ADMA Biologics Stock Forecast
Stock Price Forecast
According to 3 stock analysts, the average 12-month stock price forecast for ADMA Biologics stock is $5.67, which predicts an increase of 25.44%. The lowest target is $5.00 and the highest is $6.00. On average, analysts rate ADMA Biologics stock as a strong buy.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ADMA Biologics stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '23 | Aug '23 | Sep '23 | Oct '23 | Nov '23 | Dec '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 2 | 2 |
| Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 4 | 4 | 4 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $6 | Buy | Reiterates | $6 | +32.74% | Dec 19, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +10.62% | Nov 17, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $5 → $6 | Buy | Maintains | $5 → $6 | +32.74% | Aug 10, 2023 |
| Raymond James | Raymond James | Strong Buy Maintains $5 → $6 | Strong Buy | Maintains | $5 → $6 | +32.74% | Aug 10, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5 → $5 | Strong Buy | Maintains | $5 → $5 | +10.62% | Aug 10, 2023 |
Financial Forecast
Revenue This Year
257.85M
from 154.08M
Increased by 67.35%
Revenue Next Year
298.83M
from 257.85M
Increased by 15.89%
EPS This Year
-0.03
from -0.33
EPS Next Year
0.17
from -0.03
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | 266.7M | 309.1M | 356.5M | 415.2M | 444.1M | 484.2M |
| Avg | 257.9M | 298.8M | 343.4M | 388.1M | 406.2M | 431.4M |
| Low | 246.7M | 286.2M | 328.5M | 355.4M | 366.0M | 377.0M |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | 73.1% | 19.9% | 19.3% | 20.9% | 14.4% | 19.2% |
| Avg | 67.3% | 15.9% | 14.9% | 13.0% | 4.7% | 6.2% |
| Low | 60.1% | 11.0% | 9.9% | 3.5% | -5.7% | -7.2% |
EPS Forecast
| EPS | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | -0.02 | 0.19 | 0.34 | 0.49 | 0.54 | 0.58 |
| Avg | -0.03 | 0.17 | 0.30 | 0.47 | 0.52 | 0.56 |
| Low | -0.03 | 0.15 | 0.26 | 0.44 | 0.50 | 0.54 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | - | - | 102.7% | 63.1% | 14.1% | 11.0% |
| Avg | - | - | 82.6% | 55.1% | 10.9% | 7.8% |
| Low | - | - | 59.6% | 45.7% | 6.5% | 3.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.